HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $78,993 | -27.4% | 76,692 | -18.2% | 0.00% | – |
Q2 2023 | $108,801 | +12640.2% | 93,794 | -83.4% | 0.00% | – |
Q1 2023 | $854 | -90.3% | 565,788 | -83.9% | 0.00% | -100.0% |
Q4 2022 | $8,766 | -99.9% | 3,506,354 | +108.6% | 0.01% | +25.0% |
Q3 2022 | $7,094,000 | +489.2% | 1,680,966 | +289.4% | 0.00% | – |
Q2 2022 | $1,204,000 | -82.5% | 431,638 | -64.1% | 0.00% | -100.0% |
Q1 2022 | $6,880,000 | -25.0% | 1,202,738 | +19.7% | 0.00% | -20.0% |
Q4 2021 | $9,174,000 | +80.4% | 1,004,798 | +206.6% | 0.01% | +66.7% |
Q2 2021 | $5,086,000 | -69.8% | 327,721 | -68.5% | 0.00% | -75.0% |
Q1 2021 | $16,856,000 | +298.1% | 1,039,846 | +419.8% | 0.01% | +300.0% |
Q4 2020 | $4,234,000 | +39.9% | 200,031 | -2.1% | 0.00% | -25.0% |
Q3 2020 | $3,027,000 | -49.2% | 204,238 | -59.8% | 0.00% | -69.2% |
Q1 2020 | $5,962,000 | -64.1% | 507,854 | -28.2% | 0.01% | -38.1% |
Q4 2019 | $16,627,000 | +58.5% | 707,544 | +24.8% | 0.02% | +23.5% |
Q3 2019 | $10,488,000 | +61.4% | 566,931 | +62.2% | 0.02% | +70.0% |
Q2 2019 | $6,500,000 | +311.4% | 349,629 | +440.8% | 0.01% | +400.0% |
Q1 2019 | $1,580,000 | +20.2% | 64,650 | +55.7% | 0.00% | 0.0% |
Q3 2018 | $1,315,000 | -81.1% | 41,535 | -76.8% | 0.00% | -77.8% |
Q2 2018 | $6,968,000 | +22.1% | 179,364 | -43.1% | 0.01% | +12.5% |
Q4 2017 | $5,705,000 | -4.5% | 315,173 | -14.8% | 0.01% | -11.1% |
Q3 2017 | $5,973,000 | +155.5% | 369,874 | +119.1% | 0.01% | +125.0% |
Q2 2017 | $2,338,000 | -30.6% | 168,777 | -34.3% | 0.00% | -42.9% |
Q4 2016 | $3,368,000 | -11.3% | 257,062 | +28.5% | 0.01% | -22.2% |
Q1 2016 | $3,798,000 | -84.0% | 200,000 | -73.7% | 0.01% | -80.0% |
Q2 2015 | $23,686,000 | +140.8% | 760,146 | +12.4% | 0.04% | +150.0% |
Q1 2015 | $9,838,000 | +293.8% | 676,152 | +172.3% | 0.02% | +260.0% |
Q4 2014 | $2,498,000 | +49.6% | 248,357 | +23.9% | 0.01% | +25.0% |
Q3 2014 | $1,670,000 | -36.4% | 200,469 | -5.9% | 0.00% | -42.9% |
Q2 2014 | $2,624,000 | +9.2% | 213,006 | +23.3% | 0.01% | 0.0% |
Q1 2014 | $2,402,000 | – | 172,697 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |